| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
66,949 |
58,322 |
$5.37M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
70,453 |
63,824 |
$4.68M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
33,531 |
27,826 |
$3.73M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
65,514 |
23,047 |
$3.46M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
63,494 |
26,715 |
$2.93M |
| 80053 |
Comprehensive metabolic panel |
100,322 |
74,253 |
$2.51M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
22,947 |
18,015 |
$2.07M |
| 54161 |
|
2,455 |
2,326 |
$2.04M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
21,706 |
8,008 |
$1.74M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
16,652 |
15,708 |
$1.69M |
| 77386 |
|
7,220 |
573 |
$1.52M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
1,454 |
1,386 |
$1.49M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,350 |
7,406 |
$1.46M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
2,986 |
2,455 |
$1.43M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19,207 |
14,971 |
$1.37M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
36,803 |
26,974 |
$1.36M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15,256 |
12,878 |
$1.34M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
16,473 |
10,591 |
$1.29M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
3,181 |
2,989 |
$1.09M |
| 36415 |
Collection of venous blood by venipuncture |
32,524 |
23,393 |
$1.04M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,312 |
2,208 |
$1.02M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
1,848 |
1,773 |
$981K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14,642 |
13,473 |
$942K |
| 93304 |
|
3,062 |
2,820 |
$920K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
991 |
841 |
$847K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
5,100 |
4,809 |
$835K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,810 |
1,625 |
$825K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12,677 |
10,578 |
$817K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
58,816 |
41,841 |
$814K |
| 97162 |
|
10,066 |
9,222 |
$796K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,419 |
6,886 |
$771K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
35,116 |
28,646 |
$765K |
| 92557 |
|
9,559 |
8,916 |
$760K |
| 95782 |
|
1,342 |
1,326 |
$690K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,327 |
8,449 |
$659K |
| 97116 |
|
11,746 |
5,389 |
$657K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
4,902 |
4,067 |
$635K |
| J9312 |
Injection, rituximab, 10 mg |
849 |
573 |
$606K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
15,429 |
7,619 |
$604K |
| 94060 |
|
7,999 |
7,394 |
$571K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
31,604 |
25,424 |
$535K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,485 |
3,075 |
$511K |
| J9271 |
Injection, pembrolizumab, 1 mg |
642 |
416 |
$507K |
| 86850 |
|
15,537 |
12,320 |
$503K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
164,500 |
118,809 |
$498K |
| 97535 |
Self-care/home management training, each 15 minutes |
12,139 |
7,860 |
$485K |
| 96415 |
|
5,592 |
4,384 |
$469K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,033 |
8,414 |
$441K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,446 |
3,687 |
$419K |
| 71046 |
Radiologic examination, chest; 2 views |
32,379 |
27,228 |
$411K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,531 |
3,143 |
$407K |
| G0378 |
Hospital observation service, per hour |
6,806 |
4,680 |
$406K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
971 |
512 |
$405K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
16,766 |
7,284 |
$369K |
| 76775 |
|
6,430 |
5,815 |
$353K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,152 |
5,834 |
$343K |
| 77336 |
|
3,190 |
1,291 |
$338K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,051 |
1,794 |
$333K |
| 93308 |
|
2,779 |
2,354 |
$326K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,419 |
2,216 |
$318K |
| 92552 |
|
4,254 |
4,171 |
$302K |
| 97166 |
|
4,629 |
4,242 |
$299K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12,703 |
11,248 |
$287K |
| 92579 |
|
4,893 |
4,798 |
$283K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,471 |
6,047 |
$273K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
15,819 |
13,769 |
$268K |
| 73564 |
|
9,753 |
8,436 |
$260K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
4,254 |
3,826 |
$258K |
| 97163 |
|
3,292 |
2,982 |
$249K |
| 94010 |
|
7,363 |
6,170 |
$249K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,093 |
1,753 |
$242K |
| A9270 |
Non-covered item or service |
21,362 |
11,650 |
$236K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,079 |
916 |
$225K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,680 |
1,211 |
$223K |
| 70491 |
|
2,324 |
1,935 |
$209K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
5,134 |
4,365 |
$203K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
6,656 |
5,583 |
$201K |
| 73110 |
|
7,906 |
6,317 |
$198K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
52,348 |
43,661 |
$198K |
| 97113 |
|
4,266 |
1,640 |
$198K |
| 73610 |
|
7,812 |
6,626 |
$197K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
767 |
690 |
$196K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
673 |
503 |
$188K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,631 |
2,961 |
$188K |
| 42830 |
|
101 |
100 |
$186K |
| 76830 |
Ultrasound, transvaginal |
4,416 |
3,885 |
$186K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,566 |
2,235 |
$179K |
| 78264 |
|
1,016 |
926 |
$178K |
| 95812 |
|
648 |
616 |
$176K |
| 73130 |
|
7,051 |
5,926 |
$175K |
| 97165 |
|
2,078 |
1,902 |
$173K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,833 |
5,417 |
$170K |
| 82947 |
|
23,956 |
13,316 |
$170K |
| 78816 |
|
1,248 |
1,059 |
$169K |
| 74183 |
|
1,381 |
1,128 |
$167K |
| 95811 |
|
510 |
460 |
$166K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
7,869 |
6,095 |
$164K |
| 97161 |
|
2,186 |
1,962 |
$161K |
| 96402 |
|
1,264 |
1,007 |
$161K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15,301 |
9,227 |
$161K |
| 71250 |
|
5,142 |
4,276 |
$161K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
45,469 |
33,766 |
$156K |
| 83735 |
|
46,473 |
28,316 |
$155K |
| 74230 |
|
1,844 |
1,611 |
$153K |
| 73030 |
|
7,809 |
6,509 |
$152K |
| 86900 |
|
17,477 |
13,801 |
$152K |
| 96368 |
|
1,960 |
1,399 |
$151K |
| 36430 |
|
2,372 |
1,317 |
$148K |
| 76536 |
|
2,783 |
2,480 |
$147K |
| J3490 |
Unclassified drugs |
41,109 |
21,209 |
$145K |
| 76825 |
|
838 |
782 |
$145K |
| 73630 |
|
7,948 |
6,793 |
$140K |
| 96367 |
|
2,807 |
2,231 |
$137K |
| 70496 |
|
2,087 |
1,744 |
$137K |
| A0434 |
Specialty care transport (sct) |
588 |
515 |
$136K |
| 74018 |
|
5,404 |
4,628 |
$133K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,747 |
5,081 |
$129K |
| 72082 |
|
2,907 |
2,786 |
$129K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
582 |
477 |
$129K |
| 73140 |
|
4,179 |
3,552 |
$128K |
| 72141 |
|
1,628 |
1,415 |
$128K |
| 87070 |
|
5,926 |
4,815 |
$125K |
| J2704 |
Injection, propofol, 10 mg |
39,168 |
27,177 |
$123K |
| 92523 |
|
971 |
957 |
$121K |
| 80069 |
|
5,072 |
3,939 |
$120K |
| 76642 |
|
3,071 |
2,688 |
$118K |
| 64493 |
|
418 |
371 |
$116K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
19,088 |
16,035 |
$115K |
| 92567 |
|
17,368 |
16,544 |
$114K |
| 16020 |
|
1,329 |
917 |
$112K |
| 84484 |
|
36,368 |
18,470 |
$111K |
| 73100 |
|
3,369 |
2,805 |
$110K |
| 73590 |
|
5,049 |
4,201 |
$109K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,165 |
1,857 |
$109K |
| 70487 |
|
2,003 |
1,681 |
$108K |
| 84100 |
|
34,977 |
21,784 |
$107K |
| 73090 |
|
4,535 |
3,561 |
$102K |
| 87081 |
|
8,221 |
7,612 |
$102K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
29,615 |
23,653 |
$99K |
| 81001 |
|
37,231 |
30,223 |
$99K |
| 73070 |
|
3,900 |
3,326 |
$98K |
| 93798 |
|
1,703 |
373 |
$98K |
| 95816 |
|
639 |
598 |
$97K |
| 86141 |
|
27,717 |
23,223 |
$96K |
| 64483 |
|
458 |
415 |
$95K |
| 73560 |
|
5,850 |
4,784 |
$95K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
280 |
239 |
$93K |
| 84443 |
Thyroid stimulating hormone (TSH) |
18,493 |
15,350 |
$93K |
| 88307 |
|
2,352 |
1,698 |
$91K |
| 89051 |
|
1,283 |
1,005 |
$91K |
| J0490 |
Injection, belimumab, 10 mg |
78 |
51 |
$91K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,512 |
1,116 |
$91K |
| 80076 |
|
7,623 |
5,930 |
$89K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
22,400 |
17,323 |
$88K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,982 |
1,717 |
$84K |
| 72197 |
|
891 |
767 |
$83K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,049 |
7,922 |
$82K |
| 71045 |
Radiologic examination, chest; single view |
12,956 |
10,731 |
$82K |
| 92553 |
|
717 |
699 |
$82K |
| 93325 |
|
11,029 |
9,944 |
$81K |
| 80197 |
|
11,954 |
6,690 |
$80K |
| 93976 |
|
5,075 |
4,416 |
$80K |
| 72100 |
|
3,977 |
3,525 |
$79K |
| L3906 |
Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
818 |
704 |
$79K |
| 83605 |
|
14,220 |
9,290 |
$78K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
18,935 |
15,097 |
$77K |
| 85610 |
|
21,030 |
15,707 |
$77K |
| 81025 |
|
19,185 |
16,059 |
$77K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
494 |
361 |
$76K |
| C1769 |
Guide wire |
6,386 |
5,144 |
$75K |
| 77300 |
|
1,126 |
873 |
$75K |
| 87077 |
|
11,989 |
8,750 |
$74K |
| 83690 |
|
21,424 |
17,740 |
$73K |
| 74174 |
|
921 |
766 |
$73K |
| 83880 |
|
15,119 |
12,308 |
$73K |
| 87507 |
|
556 |
518 |
$73K |
| 93971 |
|
3,805 |
3,148 |
$71K |
| 70543 |
|
424 |
373 |
$71K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,268 |
3,122 |
$71K |
| J1644 |
Injection, heparin sodium, per 1000 units |
9,303 |
4,092 |
$71K |
| 11043 |
|
681 |
350 |
$70K |
| 86832 |
|
1,768 |
1,470 |
$70K |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
55 |
54 |
$68K |
| 36592 |
|
10,668 |
7,473 |
$68K |
| 74240 |
|
1,010 |
943 |
$68K |
| 74178 |
|
1,080 |
921 |
$67K |
| 82728 |
|
12,082 |
10,299 |
$67K |
| 62323 |
|
154 |
137 |
$66K |
| 72040 |
|
2,264 |
1,988 |
$66K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13,555 |
10,019 |
$66K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,328 |
2,133 |
$65K |
| 70486 |
|
1,755 |
1,559 |
$65K |
| 36591 |
|
5,047 |
2,718 |
$65K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
406 |
354 |
$65K |
| 73502 |
|
4,162 |
3,516 |
$64K |
| 92587 |
|
6,038 |
5,890 |
$63K |
| 87497 |
|
7,116 |
4,209 |
$63K |
| 97542 |
|
1,207 |
1,067 |
$63K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,021 |
2,726 |
$61K |
| 70480 |
|
831 |
759 |
$60K |
| 93970 |
|
2,084 |
1,722 |
$60K |
| 97167 |
|
824 |
747 |
$59K |
| 77301 |
|
134 |
121 |
$59K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
14,448 |
11,782 |
$59K |
| 96409 |
|
1,539 |
878 |
$58K |
| 77066 |
Tomosynthesis, mammo |
1,804 |
1,597 |
$57K |
| 64635 |
|
293 |
240 |
$57K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,298 |
1,228 |
$56K |
| 77334 |
|
1,148 |
647 |
$55K |
| 20680 |
|
42 |
41 |
$55K |
| 73080 |
|
1,785 |
1,530 |
$55K |
| 85027 |
|
16,937 |
12,760 |
$55K |
| 73221 |
|
541 |
484 |
$54K |
| 93356 |
|
964 |
894 |
$53K |
| 80047 |
|
3,201 |
2,654 |
$53K |
| 93017 |
|
1,256 |
1,065 |
$52K |
| 93923 |
|
1,393 |
1,189 |
$52K |
| L3913 |
Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
450 |
405 |
$50K |
| 86901 |
|
17,621 |
13,836 |
$50K |
| 80061 |
Lipid panel |
9,500 |
8,201 |
$50K |
| 97597 |
|
1,079 |
575 |
$49K |
| 27447 |
|
15 |
12 |
$48K |
| 73552 |
|
3,074 |
2,622 |
$48K |
| 93226 |
|
1,090 |
1,028 |
$48K |
| 73521 |
|
1,580 |
1,486 |
$48K |
| 49452 |
|
553 |
434 |
$47K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
22,058 |
17,373 |
$46K |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
539 |
452 |
$46K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
9,966 |
7,535 |
$43K |
| 72170 |
|
2,401 |
2,098 |
$43K |
| 73000 |
|
1,243 |
1,072 |
$43K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
5,375 |
4,488 |
$42K |
| 93271 |
|
1,063 |
990 |
$42K |
| 93922 |
|
744 |
660 |
$41K |
| 82248 |
|
25,119 |
19,995 |
$41K |
| 82803 |
|
3,796 |
3,121 |
$41K |
| 43235 |
|
280 |
240 |
$41K |
| 73600 |
|
1,489 |
1,293 |
$41K |
| 76870 |
|
1,074 |
973 |
$41K |
| 82805 |
|
4,870 |
3,746 |
$40K |
| 58661 |
|
18 |
13 |
$40K |
| 76882 |
|
961 |
827 |
$40K |
| 83970 |
|
3,458 |
2,948 |
$39K |
| 86902 |
|
1,335 |
848 |
$39K |
| 72131 |
|
1,862 |
1,558 |
$38K |
| 81003 |
|
8,976 |
7,600 |
$38K |
| 77295 |
|
59 |
41 |
$37K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
514 |
297 |
$37K |
| 88142 |
|
2,860 |
2,628 |
$37K |
| 88341 |
|
3,325 |
1,834 |
$37K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
7,046 |
5,465 |
$37K |
| 84439 |
|
8,000 |
6,839 |
$37K |
| 84702 |
|
7,987 |
6,526 |
$36K |
| 81000 |
|
5,658 |
4,413 |
$35K |
| 76885 |
|
405 |
390 |
$35K |
| 82570 |
|
7,806 |
6,190 |
$35K |
| 82784 |
|
6,496 |
5,435 |
$35K |
| 73222 |
|
89 |
83 |
$35K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
21,093 |
14,256 |
$35K |
| 88342 |
|
4,896 |
3,647 |
$35K |
| 82607 |
|
6,740 |
5,837 |
$34K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,450 |
3,605 |
$34K |
| 81002 |
|
4,391 |
4,119 |
$34K |
| 77072 |
|
967 |
928 |
$33K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,411 |
2,168 |
$33K |
| 92555 |
|
5,673 |
5,554 |
$33K |
| L8613 |
Ossicula implant |
1,407 |
1,340 |
$33K |
| 73060 |
|
1,837 |
1,488 |
$32K |
| 88304 |
|
1,637 |
1,288 |
$32K |
| 82565 |
|
4,192 |
3,422 |
$32K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
324 |
154 |
$32K |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
20 |
13 |
$32K |
| 73700 |
|
464 |
414 |
$32K |
| 96450 |
|
126 |
102 |
$32K |
| 10060 |
|
567 |
512 |
$31K |
| 85730 |
|
9,032 |
7,355 |
$31K |
| 72156 |
|
444 |
380 |
$31K |
| 12011 |
|
555 |
531 |
$30K |
| 96417 |
|
2,293 |
1,362 |
$30K |
| 86355 |
|
1,702 |
1,429 |
$29K |
| 44970 |
|
13 |
13 |
$29K |
| 96401 |
|
760 |
417 |
$29K |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
32 |
29 |
$28K |
| 70498 |
|
1,844 |
1,550 |
$28K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,076 |
663 |
$28K |
| 47562 |
|
17 |
14 |
$27K |
| 94726 |
|
3,337 |
2,953 |
$26K |
| 86359 |
|
2,366 |
1,999 |
$26K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,922 |
8,607 |
$26K |
| 99152 |
|
4,464 |
3,536 |
$26K |
| 85652 |
|
14,534 |
12,229 |
$26K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,551 |
4,997 |
$25K |
| 12001 |
|
493 |
450 |
$24K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,447 |
3,603 |
$24K |
| 93451 |
|
58 |
51 |
$24K |
| 73620 |
|
1,439 |
1,265 |
$24K |
| 77062 |
|
649 |
637 |
$24K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
431 |
355 |
$23K |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
591 |
453 |
$23K |
| L3933 |
Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment |
237 |
200 |
$23K |
| 87186 |
|
8,143 |
6,037 |
$23K |
| 86780 |
|
4,945 |
4,413 |
$23K |
| 73120 |
|
846 |
735 |
$23K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
370 |
314 |
$23K |
| 75574 |
|
313 |
275 |
$22K |
| 99153 |
Mod sedat endo service >5yrs |
3,363 |
2,674 |
$22K |
| 87400 |
|
1,778 |
1,502 |
$22K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
8,185 |
5,519 |
$22K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
9,083 |
6,745 |
$21K |
| 86833 |
|
1,857 |
1,543 |
$21K |
| 86870 |
|
682 |
537 |
$21K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,357 |
3,245 |
$21K |
| 83615 |
|
6,537 |
4,401 |
$21K |
| 82105 |
|
2,042 |
1,680 |
$20K |
| 96376 |
|
5,162 |
4,081 |
$20K |
| 93225 |
|
962 |
868 |
$20K |
| 77412 |
|
356 |
46 |
$20K |
| 20610 |
|
423 |
343 |
$20K |
| 87486 |
|
816 |
695 |
$19K |
| 82378 |
|
1,851 |
1,186 |
$19K |
| 0099U |
|
433 |
387 |
$19K |
| 70250 |
|
561 |
471 |
$19K |
| 92611 |
|
1,641 |
1,447 |
$19K |
| 72158 |
|
242 |
218 |
$19K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
2,454 |
1,964 |
$18K |
| 77080 |
|
642 |
567 |
$18K |
| 0097U |
|
192 |
176 |
$18K |
| 82330 |
|
2,641 |
1,858 |
$18K |
| 77049 |
|
85 |
81 |
$18K |
| 95819 |
|
141 |
134 |
$18K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,960 |
2,415 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
11,480 |
10,004 |
$17K |
| 96411 |
|
1,654 |
1,103 |
$17K |
| 87799 |
|
4,443 |
3,112 |
$17K |
| 73660 |
|
601 |
526 |
$17K |
| 82550 |
|
4,089 |
3,378 |
$17K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
974 |
844 |
$17K |
| 86923 |
|
1,919 |
1,287 |
$17K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
3,187 |
2,541 |
$17K |
| 87040 |
|
4,173 |
2,442 |
$17K |
| 64450 |
|
500 |
437 |
$17K |
| 85014 |
|
3,783 |
3,104 |
$17K |
| 94762 |
|
2,436 |
1,613 |
$16K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
4,430 |
1,741 |
$16K |
| 54163 |
|
12 |
12 |
$16K |
| L3702 |
Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
75 |
67 |
$16K |
| 87210 |
|
3,328 |
2,815 |
$16K |
| 72070 |
|
831 |
749 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,496 |
5,176 |
$15K |
| 78306 |
|
111 |
96 |
$15K |
| 96416 |
|
577 |
349 |
$15K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
86 |
81 |
$15K |
| 29888 |
|
14 |
13 |
$15K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
155 |
140 |
$15K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
3,476 |
2,348 |
$15K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
707 |
495 |
$14K |
| 74019 |
|
938 |
887 |
$14K |
| 73522 |
|
694 |
619 |
$14K |
| 72146 |
|
388 |
350 |
$14K |
| 88185 |
|
991 |
557 |
$14K |
| 97760 |
|
1,479 |
1,323 |
$14K |
| 70481 |
|
129 |
116 |
$14K |
| 93975 |
|
403 |
336 |
$14K |
| 86803 |
|
5,639 |
4,995 |
$14K |
| 0399T |
|
83 |
72 |
$14K |
| 94618 |
|
701 |
560 |
$14K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
4,005 |
3,207 |
$13K |
| 83540 |
|
9,340 |
8,030 |
$13K |
| 82140 |
|
2,089 |
1,756 |
$13K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,999 |
2,203 |
$13K |
| 72128 |
|
629 |
544 |
$13K |
| 87205 |
|
4,371 |
3,492 |
$13K |
| 77002 |
|
607 |
532 |
$13K |
| 77061 |
|
795 |
750 |
$13K |
| 83550 |
|
9,122 |
7,869 |
$13K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,966 |
1,427 |
$13K |
| 82043 |
|
4,022 |
3,434 |
$12K |
| 84156 |
|
5,031 |
4,078 |
$12K |
| 84145 |
|
2,970 |
2,576 |
$12K |
| 92586 |
|
111 |
110 |
$12K |
| 93270 |
|
424 |
383 |
$12K |
| 86357 |
|
628 |
541 |
$12K |
| 94729 |
|
4,465 |
3,906 |
$12K |
| 77065 |
Tomosynthesis, mammo |
719 |
640 |
$11K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
681 |
508 |
$11K |
| 64415 |
|
446 |
384 |
$11K |
| 80074 |
|
781 |
715 |
$11K |
| 87430 |
|
1,926 |
1,823 |
$11K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
19 |
12 |
$11K |
| 93926 |
|
349 |
318 |
$11K |
| 75561 |
|
39 |
39 |
$11K |
| 76937 |
|
820 |
615 |
$11K |
| 87340 |
|
5,618 |
4,929 |
$11K |
| 85379 |
|
4,000 |
3,391 |
$11K |
| C1889 |
Implantable/insertable device, not otherwise classified |
347 |
292 |
$11K |
| 93990 |
|
572 |
423 |
$10K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,346 |
1,712 |
$10K |
| 86922 |
|
1,335 |
894 |
$10K |
| 86317 |
|
2,489 |
2,111 |
$10K |
| C1758 |
Catheter, ureteral |
620 |
491 |
$10K |
| 84134 |
|
1,874 |
1,435 |
$10K |
| 83655 |
|
807 |
788 |
$10K |
| 95700 |
|
155 |
152 |
$10K |
| J9299 |
Injection, nivolumab, 1 mg |
14 |
12 |
$10K |
| 84550 |
|
7,573 |
5,137 |
$10K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,555 |
742 |
$10K |
| V2632 |
Posterior chamber intraocular lens |
606 |
481 |
$10K |
| 59025 |
Fetal non-stress test |
122 |
108 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,487 |
1,275 |
$10K |
| 77001 |
|
460 |
353 |
$9K |
| 87102 |
|
2,068 |
1,497 |
$9K |
| 86829 |
|
2,796 |
1,559 |
$9K |
| J2060 |
Injection, lorazepam, 2 mg |
2,227 |
1,660 |
$9K |
| 82670 |
|
315 |
288 |
$9K |
| 86235 |
|
1,479 |
1,211 |
$9K |
| 97014 |
|
25 |
12 |
$9K |
| 93880 |
|
227 |
185 |
$9K |
| 80320 |
|
1,933 |
1,556 |
$9K |
| 86308 |
|
1,067 |
953 |
$9K |
| 93321 |
|
5,838 |
5,161 |
$9K |
| 72157 |
|
166 |
144 |
$9K |
| 12002 |
|
235 |
210 |
$9K |
| 82247 |
|
335 |
259 |
$9K |
| J9045 |
Injection, carboplatin, 50 mg |
582 |
333 |
$8K |
| 92626 |
|
95 |
89 |
$8K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
8,044 |
6,811 |
$8K |
| 92604 |
|
258 |
217 |
$8K |
| 54300 |
|
15 |
15 |
$8K |
| 72081 |
|
186 |
176 |
$8K |
| 82950 |
|
788 |
750 |
$8K |
| 77338 |
|
135 |
122 |
$8K |
| 83020 |
|
1,991 |
1,780 |
$8K |
| 83516 |
|
2,332 |
1,842 |
$8K |
| 74160 |
|
103 |
91 |
$8K |
| J0897 |
Injection, denosumab, 1 mg |
48 |
26 |
$7K |
| 92652 |
|
188 |
181 |
$7K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
3,793 |
3,018 |
$7K |
| 82785 |
|
718 |
685 |
$7K |
| C9399 |
Unclassified drugs or biologicals |
1,995 |
1,362 |
$7K |
| 82746 |
|
3,170 |
2,732 |
$7K |
| 88108 |
|
2,279 |
1,763 |
$7K |
| 52332 |
|
28 |
24 |
$7K |
| 85048 |
|
502 |
373 |
$7K |
| 82657 |
|
14 |
13 |
$7K |
| 86762 |
|
1,760 |
1,585 |
$7K |
| 87116 |
|
1,610 |
1,126 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
826 |
699 |
$7K |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
137 |
101 |
$7K |
| 85045 |
|
7,275 |
5,966 |
$7K |
| 88311 |
|
798 |
615 |
$7K |
| 64490 |
|
14 |
13 |
$7K |
| 73200 |
|
102 |
91 |
$7K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,724 |
1,400 |
$7K |
| 43249 |
|
15 |
13 |
$6K |
| 84153 |
|
1,544 |
1,198 |
$6K |
| G0390 |
Trauma response team associated with hospital critical care service |
46 |
39 |
$6K |
| 99201 |
|
115 |
113 |
$6K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
785 |
748 |
$6K |
| 87536 |
|
559 |
439 |
$6K |
| 86480 |
|
1,768 |
1,555 |
$6K |
| 82150 |
|
1,194 |
1,010 |
$6K |
| 97164 |
|
115 |
107 |
$6K |
| 85347 |
|
1,091 |
659 |
$6K |
| 77014 |
|
295 |
43 |
$6K |
| 87206 |
|
1,602 |
1,124 |
$6K |
| 92650 |
|
97 |
95 |
$6K |
| 73020 |
|
352 |
287 |
$6K |
| 92582 |
|
682 |
659 |
$6K |
| 51701 |
|
728 |
608 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,981 |
3,676 |
$6K |
| 86920 |
|
424 |
280 |
$6K |
| 11045 |
|
39 |
13 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
1,262 |
597 |
$5K |
| 86039 |
|
1,879 |
1,595 |
$5K |
| 90715 |
|
1,730 |
1,476 |
$5K |
| 87522 |
Neg quan hep c or qual rna |
667 |
546 |
$5K |
| 88312 |
|
1,320 |
881 |
$5K |
| 72190 |
|
169 |
147 |
$5K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,214 |
1,783 |
$5K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,250 |
738 |
$5K |
| J3262 |
Injection, tocilizumab, 1 mg |
74 |
53 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,053 |
1,700 |
$5K |
| 87075 |
|
453 |
337 |
$5K |
| 30930 |
|
27 |
26 |
$5K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,067 |
962 |
$5K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
435 |
355 |
$5K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
668 |
589 |
$5K |
| 86644 |
|
1,078 |
913 |
$5K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,110 |
867 |
$5K |
| 73551 |
|
168 |
145 |
$5K |
| J1750 |
Injection, iron dextran, 50 mg |
13 |
13 |
$5K |
| 87581 |
|
815 |
694 |
$5K |
| 96112 |
|
17 |
16 |
$5K |
| 87807 |
|
340 |
327 |
$5K |
| 64400 |
|
88 |
80 |
$5K |
| 73501 |
|
308 |
263 |
$5K |
| 84132 |
|
1,422 |
1,058 |
$4K |
| 84295 |
|
1,327 |
996 |
$4K |
| 95012 |
|
443 |
435 |
$4K |
| 80165 |
|
569 |
466 |
$4K |
| 82977 |
|
3,668 |
2,535 |
$4K |
| 97750 |
|
280 |
260 |
$4K |
| 85660 |
|
1,492 |
1,065 |
$4K |
| 87305 |
|
1,630 |
892 |
$4K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
722 |
509 |
$4K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
224 |
154 |
$4K |
| 86828 |
|
478 |
414 |
$4K |
| A0436 |
Rotary wing air mileage, per statute mile |
32 |
29 |
$4K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
1,024 |
725 |
$4K |
| 84703 |
|
1,911 |
1,708 |
$4K |
| 70360 |
|
190 |
182 |
$4K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
615 |
197 |
$4K |
| 83883 |
|
1,527 |
629 |
$3K |
| J1630 |
Injection, haloperidol, up to 5 mg |
796 |
648 |
$3K |
| 84403 |
|
1,176 |
993 |
$3K |
| 88184 |
|
737 |
589 |
$3K |
| 86160 |
|
1,754 |
1,481 |
$3K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
452 |
368 |
$3K |
| 77370 |
|
49 |
43 |
$3K |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
230 |
192 |
$3K |
| 85520 |
|
569 |
375 |
$3K |
| J3471 |
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
264 |
204 |
$3K |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
869 |
442 |
$3K |
| 84165 |
|
1,412 |
1,198 |
$3K |
| 73562 |
|
190 |
160 |
$3K |
| 80164 |
|
516 |
466 |
$3K |
| 64445 |
|
163 |
139 |
$3K |
| 93320 |
|
2,793 |
2,591 |
$3K |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
238 |
197 |
$3K |
| 77073 |
|
125 |
123 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
543 |
481 |
$3K |
| 75635 |
|
29 |
26 |
$3K |
| 86880 |
|
110 |
90 |
$3K |
| 86905 |
|
573 |
384 |
$3K |
| 80177 |
|
849 |
735 |
$3K |
| 86665 |
|
1,111 |
894 |
$3K |
| 87184 |
|
1,368 |
1,048 |
$3K |
| 77290 |
|
15 |
13 |
$3K |
| 92610 |
|
26 |
26 |
$3K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
326 |
276 |
$3K |
| 85384 |
|
1,485 |
1,136 |
$3K |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
959 |
826 |
$3K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
710 |
623 |
$3K |
| 83001 |
|
717 |
641 |
$2K |
| 76377 |
|
15 |
14 |
$2K |
| 62328 |
|
14 |
12 |
$2K |
| 88313 |
|
1,173 |
649 |
$2K |
| 81378 |
|
125 |
99 |
$2K |
| 84480 |
|
1,089 |
948 |
$2K |
| 82375 |
|
1,651 |
1,315 |
$2K |
| 84146 |
|
276 |
258 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
95 |
87 |
$2K |
| 83050 |
|
1,654 |
1,315 |
$2K |
| 86787 |
|
989 |
880 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
698 |
597 |
$2K |
| 86706 |
|
409 |
336 |
$2K |
| 82962 |
|
821 |
357 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
391 |
315 |
$2K |
| 94642 |
|
119 |
104 |
$2K |
| 86704 |
|
1,329 |
1,128 |
$2K |
| 81373 |
|
90 |
57 |
$2K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,097 |
772 |
$2K |
| C1729 |
Catheter, drainage |
215 |
186 |
$2K |
| 86225 |
|
972 |
828 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
291 |
203 |
$2K |
| 90686 |
|
496 |
415 |
$2K |
| 82085 |
|
418 |
352 |
$2K |
| 36512 |
|
15 |
12 |
$2K |
| 76827 |
|
815 |
763 |
$2K |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
199 |
162 |
$2K |
| 80195 |
|
667 |
420 |
$2K |
| 72195 |
|
14 |
13 |
$2K |
| 92585 |
|
78 |
78 |
$2K |
| A4648 |
Tissue marker, implantable, any type, each |
29 |
25 |
$2K |
| Q9961 |
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
594 |
463 |
$2K |
| C1760 |
Closure device, vascular (implantable/insertable) |
17 |
12 |
$2K |
| 62321 |
|
13 |
13 |
$2K |
| 96377 |
|
20 |
12 |
$2K |
| 71271 |
|
45 |
39 |
$2K |
| 93886 |
|
44 |
41 |
$2K |
| 86146 |
|
84 |
77 |
$2K |
| J2785 |
Injection, regadenoson, 0.1 mg |
471 |
383 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
61 |
38 |
$2K |
| 93460 |
|
13 |
13 |
$2K |
| 36600 |
|
207 |
172 |
$1K |
| 83520 |
|
208 |
175 |
$1K |
| 73718 |
|
19 |
17 |
$1K |
| 82533 |
|
408 |
323 |
$1K |
| 85018 |
|
346 |
269 |
$1K |
| 86592 |
|
169 |
137 |
$1K |
| 86360 |
|
1,161 |
963 |
$1K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
1,022 |
911 |
$1K |
| 86431 |
|
784 |
675 |
$1K |
| 80321 |
|
403 |
347 |
$1K |
| J7999 |
Compounded drug, not otherwise classified |
195 |
158 |
$1K |
| 92522 |
|
28 |
26 |
$1K |
| J9190 |
Injection, fluorouracil, 500 mg |
86 |
52 |
$1K |
| 99195 |
|
578 |
400 |
$1K |
| 84630 |
|
981 |
815 |
$1K |
| 72120 |
|
56 |
52 |
$1K |
| 86256 |
|
1,074 |
921 |
$1K |
| 82397 |
|
480 |
451 |
$1K |
| 83930 |
|
575 |
475 |
$1K |
| 81376 |
|
147 |
110 |
$1K |
| 76857 |
|
37 |
31 |
$1K |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
208 |
170 |
$1K |
| 82610 |
|
276 |
266 |
$1K |
| 71101 |
|
52 |
48 |
$1K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
41 |
14 |
$1K |
| 76800 |
|
12 |
12 |
$1K |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
110 |
89 |
$1K |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
78 |
52 |
$1K |
| 85246 |
|
58 |
57 |
$1K |
| 84446 |
|
622 |
520 |
$1K |
| 84590 |
|
681 |
576 |
$1K |
| J3489 |
Injection, zoledronic acid, 1 mg |
68 |
51 |
$1K |
| 87420 |
|
32 |
32 |
$1K |
| 0296T |
|
67 |
62 |
$984.25 |
| 72050 |
|
26 |
24 |
$960.13 |
| 84311 |
|
124 |
99 |
$959.17 |
| 70355 |
|
31 |
26 |
$905.74 |
| 0297T |
|
13 |
12 |
$898.64 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
85 |
72 |
$885.27 |
| 86301 |
|
203 |
141 |
$876.99 |
| 88173 |
|
323 |
217 |
$866.18 |
| 82270 |
|
716 |
621 |
$857.52 |
| 86481 |
|
101 |
86 |
$857.22 |
| 84300 |
|
104 |
93 |
$822.74 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
136 |
126 |
$813.91 |
| 89230 |
|
28 |
28 |
$811.24 |
| 82077 |
|
2,378 |
2,002 |
$780.12 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
642 |
351 |
$764.33 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
35 |
29 |
$738.57 |
| 81374 |
|
16 |
14 |
$718.46 |
| 86003 |
|
377 |
344 |
$713.31 |
| 83521 |
|
511 |
249 |
$706.68 |
| 80175 |
|
230 |
199 |
$705.38 |
| 87493 |
|
13 |
13 |
$703.59 |
| 82945 |
|
527 |
445 |
$671.17 |
| 29515 |
|
41 |
26 |
$668.36 |
| 80323 |
|
308 |
268 |
$661.20 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
308 |
259 |
$647.79 |
| 74170 |
|
17 |
12 |
$643.07 |
| 84157 |
|
550 |
460 |
$635.13 |
| 94621 |
|
14 |
12 |
$630.82 |
| 86255 |
|
36 |
25 |
$630.54 |
| 86352 |
|
31 |
18 |
$617.70 |
| 72080 |
|
35 |
27 |
$614.96 |
| C1762 |
Connective tissue, human (includes fascia lata) |
199 |
177 |
$594.98 |
| 82103 |
|
48 |
39 |
$591.77 |
| 80202 |
|
62 |
39 |
$582.94 |
| 84520 |
|
137 |
122 |
$576.43 |
| 86334 |
|
409 |
344 |
$574.20 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
484 |
322 |
$568.75 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,269 |
765 |
$550.33 |
| 84450 |
|
464 |
290 |
$549.98 |
| 80051 |
|
116 |
104 |
$541.89 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
216 |
189 |
$538.10 |
| J1940 |
Injection, furosemide, up to 20 mg |
754 |
534 |
$524.78 |
| 80143 |
|
787 |
670 |
$513.95 |
| J0456 |
Injection, azithromycin, 500 mg |
97 |
72 |
$502.19 |
| C1780 |
Lens, intraocular (new technology) |
500 |
343 |
$493.87 |
| 29125 |
|
66 |
61 |
$493.81 |
| 91010 |
|
16 |
14 |
$485.52 |
| 86769 |
|
156 |
148 |
$462.53 |
| 85613 |
|
233 |
207 |
$453.71 |
| 82040 |
|
17 |
15 |
$445.22 |
| 97763 |
|
87 |
65 |
$441.67 |
| 86376 |
|
452 |
389 |
$425.87 |
| J1953 |
Injection, levetiracetam, 10 mg |
539 |
405 |
$424.31 |
| 73650 |
|
37 |
27 |
$416.47 |
| 80349 |
|
26 |
12 |
$411.16 |
| A4649 |
Surgical supply; miscellaneous |
151 |
127 |
$409.60 |
| 84425 |
|
584 |
504 |
$405.77 |
| 80299 |
|
18 |
12 |
$382.35 |
| J7510 |
Prednisolone oral, per 5 mg |
1,773 |
1,606 |
$382.12 |
| 64447 |
|
13 |
12 |
$378.39 |
| 84155 |
|
576 |
501 |
$364.52 |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
14 |
13 |
$363.92 |
| 87181 |
|
133 |
95 |
$344.89 |
| 72202 |
|
12 |
12 |
$333.84 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
82 |
68 |
$332.13 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
82 |
68 |
$332.13 |
| 83010 |
|
338 |
264 |
$319.84 |
| 62270 |
|
14 |
12 |
$312.86 |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
68 |
58 |
$307.76 |
| 81382 |
|
28 |
24 |
$303.34 |
| 85240 |
|
67 |
56 |
$302.80 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
154 |
108 |
$299.06 |
| 51798 |
|
201 |
176 |
$298.14 |
| 87517 |
|
85 |
68 |
$291.23 |
| 95874 |
|
212 |
165 |
$288.79 |
| A0425 |
Ground mileage, per statute mile |
963 |
849 |
$285.33 |
| 76942 |
|
28 |
26 |
$277.48 |
| 82088 |
|
43 |
38 |
$257.27 |
| 94728 |
|
31 |
28 |
$254.11 |
| 82010 |
|
744 |
601 |
$253.88 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,215 |
1,155 |
$250.27 |
| 92526 |
|
16 |
12 |
$245.52 |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
13 |
12 |
$244.17 |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
46 |
30 |
$235.57 |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
16 |
12 |
$235.46 |
| 70470 |
|
18 |
14 |
$224.82 |
| 84207 |
|
360 |
312 |
$222.00 |
| 86708 |
|
191 |
167 |
$219.58 |
| 83002 |
|
333 |
298 |
$216.89 |
| 84305 |
|
126 |
123 |
$203.06 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28 |
26 |
$193.70 |
| 86200 |
|
269 |
229 |
$193.56 |
| C9113 |
Injection, pantoprazole sodium, per vial |
449 |
260 |
$191.26 |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
113 |
93 |
$184.35 |
| 94750 |
|
53 |
48 |
$181.34 |
| J9370 |
Vincristine sulfate, 1 mg |
325 |
217 |
$174.37 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
176 |
144 |
$174.13 |
| 85097 |
|
51 |
24 |
$170.50 |
| 87529 |
|
28 |
24 |
$170.37 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
77 |
68 |
$169.99 |
| 72192 |
|
17 |
13 |
$157.03 |
| 88300 |
|
103 |
80 |
$153.06 |
| 81050 |
|
145 |
128 |
$145.26 |
| 87631 |
|
76 |
73 |
$139.18 |
| 84460 |
|
147 |
93 |
$135.96 |
| 86664 |
|
25 |
24 |
$130.06 |
| 86694 |
|
86 |
74 |
$129.89 |
| 74022 |
|
32 |
26 |
$119.88 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
38 |
25 |
$116.68 |
| 86356 |
|
168 |
125 |
$105.87 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
31 |
24 |
$104.91 |
| 85576 |
|
45 |
37 |
$102.14 |
| 72220 |
|
14 |
12 |
$99.29 |
| 94799 |
|
25 |
21 |
$97.39 |
| 80179 |
|
694 |
609 |
$96.62 |
| 84270 |
|
157 |
145 |
$87.16 |
| 86147 |
|
115 |
101 |
$80.41 |
| 82525 |
|
106 |
85 |
$77.36 |
| 91038 |
|
14 |
12 |
$75.05 |
| 64636 |
|
210 |
160 |
$74.01 |
| 94727 |
|
17 |
14 |
$70.24 |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
42 |
26 |
$65.76 |
| 86304 |
|
20 |
13 |
$63.76 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
12 |
12 |
$63.59 |
| 86800 |
|
25 |
24 |
$49.66 |
| 84244 |
|
69 |
63 |
$43.31 |
| J9267 |
Injection, paclitaxel, 1 mg |
51 |
29 |
$43.02 |
| C1788 |
Port, indwelling (implantable) |
29 |
24 |
$43.02 |
| 86364 |
|
261 |
245 |
$35.83 |
| 87106 |
|
96 |
70 |
$32.19 |
| 64494 |
|
192 |
166 |
$30.78 |
| J9070 |
Cyclophosphamide, 100 mg |
19 |
12 |
$29.80 |
| J9250 |
Methotrexate sodium, 5 mg |
473 |
332 |
$24.90 |
| 97016 |
|
43 |
24 |
$22.85 |
| 84681 |
|
28 |
26 |
$20.93 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
59 |
45 |
$16.44 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
17 |
12 |
$14.34 |
| 83935 |
|
13 |
13 |
$11.95 |
| 82627 |
|
27 |
25 |
$11.52 |
| 82104 |
|
30 |
24 |
$7.24 |
| 86777 |
|
22 |
18 |
$6.72 |
| 82310 |
|
15 |
12 |
$3.13 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
36 |
28 |
$3.11 |
| 85732 |
|
190 |
166 |
$1.25 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
35 |
32 |
$0.00 |
| 80230 |
|
104 |
99 |
$0.00 |
| 84478 |
|
40 |
28 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
54 |
48 |
$0.00 |
| 82438 |
|
28 |
28 |
$0.00 |
| 88364 |
|
24 |
13 |
$0.00 |
| 86695 |
|
18 |
15 |
$0.00 |
| 85397 |
|
28 |
28 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
41 |
25 |
$0.00 |
| 87625 |
|
17 |
14 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
15 |
13 |
$0.00 |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
13 |
12 |
$0.00 |
| 86381 |
|
16 |
12 |
$0.00 |
| 85032 |
|
15 |
13 |
$0.00 |
| C1781 |
Mesh (implantable) |
15 |
12 |
$0.00 |
| J0713 |
Injection, ceftazidime, per 500 mg |
28 |
26 |
$0.00 |
| 94760 |
|
20 |
14 |
$0.00 |
| 82360 |
|
18 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
562 |
433 |
$0.00 |
| 23350 |
|
32 |
28 |
$0.00 |
| 89050 |
|
30 |
26 |
$0.00 |
| 87107 |
|
37 |
29 |
$0.00 |
| 88237 |
|
55 |
38 |
$0.00 |
| 88302 |
|
19 |
12 |
$0.00 |
| C1776 |
Joint device (implantable) |
29 |
25 |
$0.00 |
| 38222 |
|
14 |
13 |
$0.00 |
| 86696 |
|
18 |
15 |
$0.00 |
| 86015 |
|
22 |
18 |
$0.00 |
| 88262 |
|
53 |
36 |
$0.00 |
| 64616 |
|
15 |
12 |
$0.00 |
| 88365 |
|
25 |
16 |
$0.00 |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
14 |
14 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
13 |
$0.00 |